AMY CLARONI: Open Payments
NPI 1689281206 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,285 in 85 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,684 · 2025 $2,285
Food & beverage: $2,285
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $1,021 |
| Alnylam Pharmaceuticals Inc. | 11 | $139 |
| Amgen Inc. | 23 | $138 |
| Novartis Pharmaceuticals Corporation | 7 | $120 |
| PFIZER INC. | 6 | $119 |
| E.R. Squibb & Sons, L.L.C. | 7 | $107 |
| Edwards Lifesciences Corporation | 3 | $95 |
| SCPHARMACEUTICALS INC. | 5 | $88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $87 |
| AstraZeneca Pharmaceuticals LP | 5 | $80 |
Products named: Rapiblyk, ONPATTRO, REPATHA, LEQVIO, FUROSCIX, JARDIANCE, ELIQUIS, CAMZYOS.
Industry payments across NY — which companies pay providers there.
